<?xml version="1.0" ?>
<document id="28379297">
  <sentence id="28379297.s0" text="Here, we hypothesize that proline biosynthetic process might be a novel prognostic biomarker and therapeutic target for breast cancer.">
    <entity charOffset="26-54" id="28379297.s0.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="127-133" id="28379297.s0.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="28379297.s0.e0" e2="28379297.s0.e1" id="28379297.s0.p0" relation="true"/>
  </sentence>
  <sentence id="28379297.s1" text="In this study, breast cancer tissue samples were obtained from Zhejiang University (ZJU negative regulation of transcription, DNA-templated).">
    <entity charOffset="22-28" id="28379297.s1.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="88-139" id="28379297.s1.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="28379297.s1.e0" e2="28379297.s1.e1" id="28379297.s1.p0" relation="true"/>
  </sentence>
  <sentence id="28379297.s2" text="The prognostic significance and performance of proline biosynthetic process mRNA were validated on 13 worldwide independent microarray data negative regulation of transcription, DNA-templateds, composed of 2500 assessable breast cancer cases.">
    <entity charOffset="47-75" id="28379297.s2.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="140-191" id="28379297.s2.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="229-235" id="28379297.s2.e2" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="28379297.s2.e0" e2="28379297.s2.e2" id="28379297.s2.p0" relation="true"/>
    <pair e1="28379297.s2.e1" e2="28379297.s2.e2" id="28379297.s2.p1" relation="true"/>
  </sentence>
  <sentence id="28379297.s3" text="Our findings revealed that both proline biosynthetic process mRNA and protein expression were significantly associated with tumor size, grade and invasive molecular subtypes of breast cancers.">
    <entity charOffset="32-60" id="28379297.s3.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="124-129" id="28379297.s3.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="184-190" id="28379297.s3.e2" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="28379297.s3.e0" e2="28379297.s3.e2" id="28379297.s3.p0" relation="true"/>
    <pair e1="28379297.s3.e0" e2="28379297.s3.e1" id="28379297.s3.p1" relation="true"/>
  </sentence>
  <sentence id="28379297.s4" text="Further population study also validated that chemotherapy significantly improved survival in early-stage breast cancer patients with low proline biosynthetic process expression levels.">
    <entity charOffset="112-118" id="28379297.s4.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="137-165" id="28379297.s4.e1" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <pair e1="28379297.s4.e0" e2="28379297.s4.e1" id="28379297.s4.p0" relation="true"/>
  </sentence>
  <sentence id="28379297.s5" text="Therefore, proline biosynthetic process might serve as a prognostic biomaker for either ER-positive or ER-negative breast cancer subtypes and can also be a potential target for breast cancer therapy">
    <entity charOffset="11-39" id="28379297.s5.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="122-128" id="28379297.s5.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="28379297.s5.e0" e2="28379297.s5.e1" id="28379297.s5.p0" relation="true"/>
  </sentence>
</document>
